Blog

All the latest news from Check4Cancer
PREDICT model wins research excellence award
The PREDICT breast cancer survival and treatment prediction model won the People's Choice Award at the Office for National St...
2018 Finalist - Innovators and Leaders - LaingBuisson Awards
A finalist in the 'Rising Star' category of the LaingBuisson Health & Care Awards 2018.  Under Professor Gordon Wish...
Home HPV tests as good as clinician collected cervical samples
A recent US study published in Obstetrics & Gynecology has confirmed the prevalence of high-risk HPV types detected by se...
AXA PPP enhances prostate cancer diagnosis pathway
AXA PPP healthcare has teamed up with screening service, Check4Cancer, to enhance its prostate cancer diagnosis pathway. ...
Evidence led services impress the judges at the Health Investor Awards
It was third time lucky for Check4Cancer at the Health Investor Awards earlier this month.
Clinical excellence in One Stop pathway audit data presented at Association of Breast Surgery Conference
Professor Gordon Wishart, Chief Medical Officer of Check4Cancer, presents audit results from its private breast can...
Check4Cancer wins Diagnostics Provider of the Year at the 2018 Health Investor Awards
Check4Cancer is delighted to announce it has been awarded ‘Diagnostics provider of the year’ at the 2018 Health...
Not quite the "Holy Grail" cancer blood test yet
Professor Gordon Wishart, Chief Medical Officer at Check4Cancer comments on yesterday's front page Telegraph article ("Holy G...
Check4Cancer appoints Louise Mills as Clinical Services Director
Check4Cancer is delighted to announce the appointment of Louise Mills as Director of Clinical Services.
Private providers expect surge in mammogram requests
Private providers of screening mammograms such as BreastHealth UK (www.breasthealthuk.com) are expecting a surge in...
Third time lucky?!! Check4Cancer finalist in Health Investor Award for Diagnostics Provider of the Year
By working closely with large corporate clients and UK private medical insurance companies, Check4Cancer has been able to mod...
'Gene-ius' Your DNA can tell you how likely you are to develop breast cancer
Cambridge Magazine features Professor Gordon Wishart and the Check4Cancer team talking about MyBreastRisk, the first DNA sali...
Clinical governance in private hospitals
‘How safe is your operation’ (BBC Panorama, 16.10.17) questions safety of surgical procedures in private sector. Pr...
MyBreastRisk - new test launched!
BreastHealth UK, part of the Check4Cancer group, launches MyBreastRisk - the first commercially available test that combines ...
Check4Cancer leads the way post Paterson
The Paterson debacle will have damaged public confidence in private breast cancer diagnostics.  In response, Check4Canc...
Finalist in three categories at LaingBuisson healthcare awards for excellence 2017
   Check4Cancer is delighted to have been shortlisted as finalist in three separate categories of the Laing B...
Call for Whole Genome Sequencing to be offered to all cancer patients
Professor Dame Sally Davies, Chief Medical Officer for England, calls for Whole Genome Sequencing to be offered to all...
Cancer in the workplace and what it means for HR
A cancer diagnosis leads to a ripple effect across an entire organisation, presenting particular challenges in terms of ...
Check4Cancer & Cigna finalists for second year in ‘Best Diagnostics Provider’ category at Health Investor Awards
Check4Cancer and Cigna have been working together for the past 14 months to tackle early detection of breast cancer and skin ...
Prof Gordon Wishart, Chief Medical Officer at Check4Cancer to feature on Cambridge TV discussing PREDICT algorithm for new ONCOassist app
ONCOassist app adds PREDICT algorithm, licensed from Cambridge Enterprise, to help doctors make critical treatment decisions ...
Employee Benefits Live
Check4Cancer will be exhibiting at the largest dedicated reward and benefits event in Europe – Employee Benefits ...
Skin cancer – and the importance of protecting your child
With schools having broken up for the summer holidays and long days ahead, it’s more important then ever for parents to con...
Check4Cancer and Cigna UK shortlisted for ‘Diagnostics care provider of the year’ at Health Investor Awards 2016
In June 2016, Check4Cancer and Cigna UK were shortlisted for ‘Diagnostics care provider of the year’ at Health Investor Awards 2016.
Check4Cancer and BNY Mellon runners-up at Employee Benefits Awards 2016
Check4Cancer and BNY Mellon received recognition at the Employee Benefits Awards 2016, achieving runner up position for ‘Be...